Galera Therapeutics
United States
unknown
unknown
Stage
1
Investors
About
Galera Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies targeting oxidative stress to treat pulmonary and other serious diseases.
Explore Galera Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.